OGMNX
Price
$31.16
Change
+$0.94 (+3.11%)
Updated
Apr 10 closing price
Net Assets
2.34B
OGMYX
Price
$33.08
Change
+$0.99 (+3.09%)
Updated
Apr 10 closing price
Net Assets
2.34B
Ad is loading...

OGMNX vs OGMYX

Header iconOGMNX vs OGMYX Comparison
Open Charts OGMNX vs OGMYXBanner chart's image
Invesco Gold & Special Minerals R
Price$31.16
Change+$0.94 (+3.11%)
VolumeN/A
Net Assets2.34B
Invesco Gold & Special Minerals Y
Price$33.08
Change+$0.99 (+3.09%)
VolumeN/A
Net Assets2.34B
OGMNX vs OGMYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OGMNX vs. OGMYX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGMNX is a Buy and OGMYX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
OGMNX (2.34B) and OGMYX (2.34B) have equal amount of cash in the bank . OGMYX pays higher dividends than OGMNX: OGMYX (0.80) vs OGMNX (0.65). OGMNX was incepted earlier than OGMYX: OGMNX (24 years) vs OGMYX (15 years). OGMNX (1.36) is less costly to investors than OGMYX (0.86). OGMNX (30.00) and OGMYX (30.00) have comparable annual turnover. OGMNX (1000) and OGMYX (1000) have matching initial minimum investment requirements. OGMYX (31.15) and OGMNX (30.47) have marching annual gain over last year. OGMYX return over 5 years is better than : 81.82 vs. OGMNX (77.30).
OGMNXOGMYXOGMNX / OGMYX
Total Expense Ratio1.360.86158%
Annual Report Gross Expense Ratio1.360.86158%
Fund Existence24 years15 years-
Gain YTD24.67024.81599%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.34B2.34B100%
Annual Yield % from dividends0.650.8081%
Returns for 1 year30.4731.1598%
Returns for 3 years8.8810.5384%
Returns for 5 years77.3081.8294%
Returns for 10 years178.03191.6593%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HAGIX68.58N/A
N/A
Carillon Eagle Mid Cap Growth I
MRJIX10.39N/A
N/A
Morgan Stanley Multi-Asset Real Return I
USEMX19.48N/A
N/A
Victory Emerging Markets
LMORX32.50N/A
N/A
Patient Opportunity R
TARKX24.20N/A
N/A
Tarkio